We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRX
1876
DELISTED
Catalyst Pharmaceutical
CPRX
$212K ﹤0.01%
45,807
OPCH icon
1877
Option Care Health
OPCH
$3.57B
$211K ﹤0.01%
15,212
CFB
1878
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$211K ﹤0.01%
21,534
THFF icon
1879
First Financial Corp
THFF
$970M
$210K ﹤0.01%
5,707
CTT
1880
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$209K ﹤0.01%
23,620
ACEL icon
1881
Accel Entertainment
ACEL
$1B
$208K ﹤0.01%
+21,630
New +$198K
RESI
1882
DELISTED
Front Yard Residential Corporation Common Stock
RESI
$208K ﹤0.01%
23,934
REX icon
1883
REX American Resources
REX
$1.44B
$207K ﹤0.01%
17,934
RMR icon
1884
The RMR Group
RMR
$337M
$207K ﹤0.01%
7,008
POLY
1885
DELISTED
Plantronics, Inc.
POLY
$206K ﹤0.01%
14,059
PI icon
1886
Impinj
PI
$5.49B
$206K ﹤0.01%
7,512
VKTX icon
1887
Viking Therapeutics
VKTX
$3.97B
$206K ﹤0.01%
28,602
TG icon
1888
Tredegar Corp
TG
$281M
$206K ﹤0.01%
13,367
LL
1889
DELISTED
LL Flooring Holdings, Inc.
LL
$206K ﹤0.01%
+14,844
New +$126K
AVD icon
1890
American Vanguard Corp
AVD
$64M
$205K ﹤0.01%
14,887
FLXN
1891
DELISTED
Flexion Therapeutics, Inc.
FLXN
$204K ﹤0.01%
15,518
LITS
1892
Lite Strategy Inc
LITS
$31.4M
$204K ﹤0.01%
+2,465
New +$149K
ARCH
1893
DELISTED
Arch Resources, Inc.
ARCH
$204K ﹤0.01%
7,165
HWKN icon
1894
Hawkins
HWKN
$2.7B
$203K ﹤0.01%
9,556
CDMO
1895
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$203K ﹤0.01%
30,862
DCOM icon
1896
Dime Commercial Bancshares
DCOM
$1.81B
$203K ﹤0.01%
8,870
GERN icon
1897
Geron
GERN
$1.01B
$202K ﹤0.01%
92,818
LMAT icon
1898
LeMaitre Vascular
LMAT
$1.88B
$202K ﹤0.01%
7,651
TGI
1899
DELISTED
Triumph Group
TGI
$202K ﹤0.01%
22,400
BANC icon
1900
Banc of California
BANC
$3.1B
$202K ﹤0.01%
18,620

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.